Klingman & Associates’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.42M | Buy |
18,072
+280
| +2% | +$65.2K | 0.21% | 50 |
|
|
2025
Q4 | $3.68M | Buy |
17,792
+191
| +1% | +$37.8K | 0.18% | 56 |
|
|
2025
Q3 | $3.26M | Sell |
17,601
-657
| -4% | -$113K | 0.16% | 57 |
|
|
2025
Q2 | $2.79M | Buy |
18,258
+1,274
| +8% | +$196K | 0.15% | 61 |
|
|
2025
Q1 | $2.82M | Buy |
16,984
+2,005
| +13% | +$314K | 0.17% | 58 |
|
|
2024
Q4 | $2.17M | Sell |
14,979
-336
| -2% | -$52.1K | 0.13% | 67 |
|
|
2024
Q3 | $2.48M | Buy |
15,315
+214
| +1% | +$34.1K | 0.15% | 64 |
|
|
2024
Q2 | $2.21M | Sell |
15,101
-578
| -4% | -$86K | 0.15% | 62 |
|
|
2024
Q1 | $2.48M | Sell |
15,679
-149
| -0.9% | -$23.7K | 0.17% | 57 |
|
|
2023
Q4 | $2.48M | Sell |
15,828
-31
| -0.2% | -$4.75K | 0.18% | 55 |
|
|
2023
Q3 | $2.47M | Sell |
15,859
-282
| -2% | -$46.5K | 0.2% | 53 |
|
|
2023
Q2 | $2.67M | Sell |
16,141
-1,150
| -7% | -$186K | 0.22% | 49 |
|
|
2023
Q1 | $2.68M | Sell |
17,291
-224
| -1% | -$36.2K | 0.23% | 45 |
|
|
2022
Q4 | $3.09M | Buy |
17,515
+254
| +1% | +$43.9K | 0.27% | 44 |
|
|
2022
Q3 | $2.82M | Sell |
17,261
-356
| -2% | -$60.2K | 0.28% | 43 |
|
|
2022
Q2 | $3.13M | Sell |
17,617
-144
| -0.8% | -$25.7K | 0.31% | 41 |
|
|
2022
Q1 | $3.15M | Buy |
17,761
+4,716
| +36% | +$802K | 0.27% | 38 |
|
|
2021
Q4 | $2.23M | Buy |
13,045
+150
| +1% | +$24.6K | 0.19% | 46 |
|
|
2021
Q3 | $2.08M | Buy |
12,895
+130
| +1% | +$22.2K | 0.19% | 46 |
|
|
2021
Q2 | $2.1M | Sell |
12,765
-1,527
| -11% | -$253K | 0.2% | 45 |
|
|
2021
Q1 | $2.35M | Buy |
14,292
+1,304
| +10% | +$211K | 0.24% | 39 |
|
|
2020
Q4 | $2.04M | Buy |
12,988
+2,700
| +26% | +$398K | 0.24% | 40 |
|
|
2020
Q3 | $1.53M | Buy |
10,288
+1,125
| +12% | +$166K | 0.21% | 43 |
|
|
2020
Q2 | $1.29M | Buy |
9,163
+300
| +3% | +$43.7K | 0.2% | 48 |
|
|
2020
Q1 | $1.16M | Buy |
8,863
+804
| +10% | +$114K | 0.24% | 49 |
|
|
2019
Q4 | $1.18M | Buy |
8,059
+26
| +0.3% | +$3.53K | 0.19% | 46 |
|
|
2019
Q3 | $1.04M | Sell |
8,033
-34
| -0.4% | -$4.48K | 0.19% | 50 |
|
|
2019
Q2 | $1.12M | Buy |
8,067
+34
| +0.4% | +$4.71K | 0.21% | 47 |
|
|
2019
Q1 | $1.12M | Buy |
8,033
+100
| +1% | +$13.4K | 0.22% | 46 |
|
|
2018
Q4 | $1.02M | Hold |
7,933
| – | – | 0.23% | 44 |
|
|
2018
Q3 | $1.1M | Hold |
7,933
| – | – | 0.22% | 40 |
|
|
2018
Q2 | $963K | Sell |
7,933
-84
| -1% | -$10.5K | 0.21% | 42 |
|
|
2018
Q1 | $1.03M | Sell |
8,017
-7,913
| -50% | -$1.07M | 0.23% | 39 |
|
|
2017
Q4 | $2.23M | Sell |
15,930
-10,777
| -40% | -$1.5M | 0.49% | 27 |
|
|
2017
Q3 | $3.47M | Buy |
26,707
+22,512
| +537% | +$2.98M | 0.85% | 22 |
|
|
2017
Q2 | $555K | Buy |
4,195
+556
| +15% | +$70.9K | 0.15% | 53 |
|
|
2017
Q1 | $453K | Sell |
3,639
-32
| -0.9% | -$3.82K | 0.13% | 62 |
|
|
2016
Q4 | $423K | Sell |
3,671
-175
| -5% | -$20.2K | 0.13% | 59 |
|
|
2016
Q3 | $454K | Buy |
3,846
+175
| +5% | +$21.2K | 0.14% | 59 |
|
|
2016
Q2 | $445K | Hold |
3,671
| – | – | 0.14% | 57 |
|
|
2016
Q1 | $397K | Sell |
3,671
-1,500
| -29% | -$155K | 0.14% | 67 |
|
|
2015
Q4 | $531K | Sell |
5,171
-1,600
| -24% | -$161K | 0.2% | 59 |
|
|
2015
Q3 | $632K | Buy |
6,771
+2,485
| +58% | +$240K | 0.25% | 49 |
|
|
2015
Q2 | $418K | Buy |
4,286
+365
| +9% | +$36.6K | 0.16% | 57 |
|
|
2015
Q1 | $394K | Buy |
3,921
+441
| +13% | +$44.8K | 0.16% | 58 |
|
|
2014
Q4 | $363K | Buy |
+3,480
| New | +$367K | 0.15% | 63 |
|
Other funds holding JNJ
VCM
VPM
Klingman & Associates's JNJ Position: Q1 2026 in Review
Klingman & Associates increased its Johnson & Johnson (JNJ) stake by 1.6% in Q1 2026, buying an estimated $65.2K and bringing the position to 18,072 shares worth $4.42M. The position accounts for 0.21% of the portfolio, ranked #50.
Klingman & Associates first reported a position in JNJ in Q4 2014 and has held it in 46 quarters since. 4,615 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Klingman & Associates held 18,072 shares of Johnson & Johnson worth $4.42M as of Q1 2026.
- Klingman & Associates bought 280 Johnson & Johnson shares in Q1 2026, an estimated $65.2K.
- Johnson & Johnson made up 0.21% of Klingman & Associates's portfolio in Q1 2026, its #50 holding.
- Klingman & Associates first reported a position in Johnson & Johnson in Q4 2014 and has held it in 46 quarters since.
- 4,615 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.